In a May article in Health Affairs , we proposed that the federal government consider using an existing law to negotiate or compel lower drug prices in the United States for certain important drugs with excessive prices. We’ve been gratified at the interest
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/07/28/why-government-patent-use-to-lower-drug-costs-wont-stifle-innovation/
Posted
Jul 28 2016, 08:30 AM
by
Health Affairs BlogHealth Affairs Blog